247 related articles for article (PubMed ID: 25604494)
1. Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand.
Heaps JM; Sithinamsuwan P; Paul R; Lerdlum S; Pothisri M; Clifford D; Tipsuk S; Catella S; Busovaca E; Fletcher JL; Raudabaugh B; Ratto-Kim S; Valcour V; Ananworanich J;
J Neurovirol; 2015 Apr; 21(2):105-12. PubMed ID: 25604494
[TBL] [Abstract][Full Text] [Related]
2. White matter damage, neuroinflammation, and neuronal integrity in HAND.
Alakkas A; Ellis RJ; Watson CW; Umlauf A; Heaton RK; Letendre S; Collier A; Marra C; Clifford DB; Gelman B; Sacktor N; Morgello S; Simpson D; McCutchan JA; Kallianpur A; Gianella S; Marcotte T; Grant I; Fennema-Notestine C;
J Neurovirol; 2019 Feb; 25(1):32-41. PubMed ID: 30291567
[TBL] [Abstract][Full Text] [Related]
3. Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection.
Nichols MJ; Gates TM; Soares JR; Moffat KJ; Rae CD; Brew BJ; Cysique LA
AIDS; 2019 Jan; 33(1):55-66. PubMed ID: 30325766
[TBL] [Abstract][Full Text] [Related]
4. Cognitive disorders in HIV-infected patients: are they HIV-related?
Bonnet F; Amieva H; Marquant F; Bernard C; Bruyand M; Dauchy FA; Mercié P; Greib C; Richert L; Neau D; Catheline G; Dehail P; Dabis F; Morlat P; Dartigues JF; Chêne G;
AIDS; 2013 Jan; 27(3):391-400. PubMed ID: 23079813
[TBL] [Abstract][Full Text] [Related]
5. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.
Cohen RA; Harezlak J; Schifitto G; Hana G; Clark U; Gongvatana A; Paul R; Taylor M; Thompson P; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B
J Neurovirol; 2010 Feb; 16(1):25-32. PubMed ID: 20113183
[TBL] [Abstract][Full Text] [Related]
6. Neuroimaging markers of human immunodeficiency virus infection in South Africa.
Heaps JM; Joska J; Hoare J; Ortega M; Agrawal A; Seedat S; Ances BM; Stein DJ; Paul R
J Neurovirol; 2012 Jun; 18(3):151-6. PubMed ID: 22528474
[TBL] [Abstract][Full Text] [Related]
7. Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.
Vassallo M; Durant J; Lebrun-Frenay C; Fabre R; Ticchioni M; Andersen S; DeSalvador F; Harvey-Langton A; Dunais B; Cohen-Codar I; Montagne N; Cua E; Fredouille-Heripret L; Laffon M; Cottalorda J; Dellamonica P; Pradier C
HIV Med; 2015 Aug; 16(7):431-40. PubMed ID: 25981452
[TBL] [Abstract][Full Text] [Related]
8. Effects of perinatal HIV-infection on the cortical thickness and subcortical gray matter volumes in young adulthood.
Ruiz-Saez B; García MM; de Aragon AM; Gil-Correa M; Melero H; Malpica NA; de Ory SJ; Zamora B; Guillen S; Rojo P; Falcon-Neyra L; Alvarez A; Fernandez P; Lorente-Jareño ML; Ramos JT; Sainz T; Velo C; Navarro ML; Gonzalez-Tomé MI;
Medicine (Baltimore); 2021 Apr; 100(15):e25403. PubMed ID: 33847637
[TBL] [Abstract][Full Text] [Related]
9. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.
Greven CU; Bralten J; Mennes M; O'Dwyer L; van Hulzen KJ; Rommelse N; Schweren LJ; Hoekstra PJ; Hartman CA; Heslenfeld D; Oosterlaan J; Faraone SV; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar JK
JAMA Psychiatry; 2015 May; 72(5):490-9. PubMed ID: 25785435
[TBL] [Abstract][Full Text] [Related]
10. A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.
Vassallo M; Fabre R; Durant J; Lebrun-Frenay C; Joly H; Ticchioni M; DeSalvador F; Harvey-Langton A; Dunais B; Laffon M; Cottalorda J; Dellamonica P; Pradier C
J Neurovirol; 2017 Apr; 23(2):216-225. PubMed ID: 27815816
[TBL] [Abstract][Full Text] [Related]
11. HIV DNA in CD14+ reservoirs is associated with regional brain atrophy in patients naive to combination antiretroviral therapy.
Kallianpur KJ; Valcour VG; Lerdlum S; Busovaca E; Agsalda M; Sithinamsuwan P; Chalermchai T; Fletcher JL; Tipsuk S; Shikuma CM; Shiramizu BT; Ananworanich J;
AIDS; 2014 Jul; 28(11):1619-24. PubMed ID: 25232899
[TBL] [Abstract][Full Text] [Related]
12. Subcortical Atrophy in Cognitive Impairment and Dementia.
Hilal S; Amin SM; Venketasubramanian N; Niessen WJ; Vrooman H; Wong TY; Chen C; Ikram MK
J Alzheimers Dis; 2015; 48(3):813-23. PubMed ID: 26402115
[TBL] [Abstract][Full Text] [Related]
13. Lower total and regional grey matter brain volumes in youth with perinatally-acquired HIV infection: Associations with HIV disease severity, substance use, and cognition.
Lewis-de Los Angeles CP; Williams PL; Huo Y; Wang SD; Uban KA; Herting MM; Malee K; Yogev R; Csernansky JG; Nichols S; Van Dyke RB; Sowell ER; Wang L;
Brain Behav Immun; 2017 May; 62():100-109. PubMed ID: 28089557
[TBL] [Abstract][Full Text] [Related]
14. Regional Cerebral Gray Matter Volume in HIV-Positive Patients with Executive Function Deficits.
Corrêa DG; Zimmermann N; Netto TM; Tukamoto G; Ventura N; de Castro Bellini Leite S; Cabral RF; Fonseca RP; Bahia PR; Gasparetto EL
J Neuroimaging; 2016 Jul; 26(4):450-7. PubMed ID: 26780881
[TBL] [Abstract][Full Text] [Related]
15. Association of Brain Structure Changes and Cognitive Function With Combination Antiretroviral Therapy in HIV-Positive Individuals.
Sanford R; Fellows LK; Ances BM; Collins DL
JAMA Neurol; 2018 Jan; 75(1):72-79. PubMed ID: 29131878
[TBL] [Abstract][Full Text] [Related]
16. Independent effects of HIV, aging, and HAART on brain volumetric measures.
Ances BM; Ortega M; Vaida F; Heaps J; Paul R
J Acquir Immune Defic Syndr; 2012 Apr; 59(5):469-77. PubMed ID: 22269799
[TBL] [Abstract][Full Text] [Related]
17. Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Patients Older Than 60 Years.
Clifford KM; Samboju V; Cobigo Y; Milanini B; Marx GA; Hellmuth JM; Rosen HJ; Kramer JH; Allen IE; Valcour VG
J Acquir Immune Defic Syndr; 2017 Nov; 76(3):289-297. PubMed ID: 28650401
[TBL] [Abstract][Full Text] [Related]
18. Association of Immunosuppression and Viral Load With Subcortical Brain Volume in an International Sample of People Living With HIV.
Nir TM; Fouche JP; Ananworanich J; Ances BM; Boban J; Brew BJ; Chaganti JR; Chang L; Ching CRK; Cysique LA; Ernst T; Faskowitz J; Gupta V; Harezlak J; Heaps-Woodruff JM; Hinkin CH; Hoare J; Joska JA; Kallianpur KJ; Kuhn T; Lam HY; Law M; Lebrun-Frénay C; Levine AJ; Mondot L; Nakamoto BK; Navia BA; Pennec X; Porges EC; Salminen LE; Shikuma CM; Surento W; Thames AD; Valcour V; Vassallo M; Woods AJ; Thompson PM; Cohen RA; Paul R; Stein DJ; Jahanshad N
JAMA Netw Open; 2021 Jan; 4(1):e2031190. PubMed ID: 33449093
[TBL] [Abstract][Full Text] [Related]
19. Combination antiretroviral therapy improves cognitive performance and functional connectivity in treatment-naïve HIV-infected individuals.
Zhuang Y; Qiu X; Wang L; Ma Q; Mapstone M; Luque A; Weber M; Tivarus M; Miller E; Arduino RC; Zhong J; Schifitto G
J Neurovirol; 2017 Oct; 23(5):704-712. PubMed ID: 28791662
[TBL] [Abstract][Full Text] [Related]
20. Contemporary trends in HIV-associated neurocognitive disorders in Ghana.
Sarfo FS; Kyem G; Asibey SO; Tagge R; Ovbiagele B
Clin Neurol Neurosurg; 2021 Nov; 210():107003. PubMed ID: 34715557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
